PBP logo

Probiotec Stock Price

Symbol: ASX:PBPMarket Cap: AU$242.3mCategory: Pharmaceuticals & Biotech

PBP Share Price Performance

PBP Community Fair Values

    Recent PBP News & Updates

    No updates

    Probiotec Limited Key Details

    AU$221.2m

    Revenue

    AU$155.0m

    Cost of Revenue

    AU$66.3m

    Gross Profit

    AU$57.6m

    Other Expenses

    AU$8.7m

    Earnings

    Last Reported Earnings
    Dec 31, 2023
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    0.11
    Gross Margin
    29.95%
    Net Profit Margin
    3.93%
    Debt/Equity Ratio
    52.5%

    Probiotec Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About PBP

    Founded
    1996
    Employees
    n/a
    CEO
    Wesley Stringer
    WebsiteView website
    www.probiotec.com.au

    Probiotec Limited engages in the development, manufacture, packing, distribution, and sale of prescription and over the counter pharmaceuticals, complementary medicines and consumer health products, and fast-moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coatings; blister packs, bottles, sachets, tubs, and tubes; liquids, creams, gels, lotions, ointments, and powders and powder blends. It is also involved in analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. The company was incorporated in 1996 and is headquartered in Laverton North, Australia.

    Australian Market Performance

    • 7 Days: -0.2%
    • 3 Months: 5.5%
    • 1 Year: 8.6%
    • Year to Date: 5.1%
    Over the last 7 days, the market has remained flat, although notably the Materials sector declined by 4.2%. As for the longer term, the market has risen 8.6% in the past 12 months. Earnings are forecast to grow by 11% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading